The Giant Cell Arteritis Patient Reported Outcome Measure (GCA-PRO) is now available to licence
The GCA-PRO is a validated outcome measure for use in clinical trials, observation studies and clinical practice. It can also be used as a communication tool between patients and their clinicians, to highlight areas of greatest importance to patients, within face to face or online consultations.